Enhancing Collaboration with the FDA through MedWatch Plus
As market demand increases the need for quick product cycles and the distribution of regulated products, the ability to react quickly to an adverse event must be considered. This trend has led to an initiative within the FDA to increase the ability to collaborate and communicate more quickly with reporting organizations. This is where MedWatch Plus comes in.

This white paper will provide an overview of the benefits and best practices of using the FDA's MedWatch Plus initiative for electronic adverse event reporting within the Pharmaceuticals industry, as well as other FDA-regulated organizations.

After completing the registration form you will have access to download the white paper.

EtQ, Inc's privacy policy
All fields are required.
*
E-mail Address
*
First Name
*
Last Name
*
Phone
*
Job Title
*
Company
*
Street Address
Street Address 2
*
City
*
State/Province
*
Zip Code
*
Country
*
Are you currently Evaluating Quality and Compliance Management Solutions?
Yes - Currently evaluating
 
Yes- We plan to evaluate in the next 6 months
 
Yes - We plan to evaluate in the next 1-2 years
 
Yes - We are building an in-house solution
 
No - We do not have plans to evaluate an QMS solution
 
Other
 
If you answered "YES" to Question #1, what solutions are you evaluating?
Sparta Systems
Pilgrim Software
MasterControl
EtQ
In-house Solution
Other
 
*
What is your primary purpose for evaluating a QMS solution?
Manage and Track CAPAs
Adverse Event Tracking
Document Control and Training
Nonconformance Tracking
Risk-Based Quality Management
All of the Above
Other